Search publications

Publications

  • Sourbron, J, Auvin, S, Arzimanoglou A, Cross, JH, Hartmann, H, Pressler, R, Riney, K, Sugai, K, Wilmshurst, JM, Yozawitz, E and Lagae, L.

    Medical treatment in infants and young children with epilepsy: Off-label use of antiseizure medications. Survey Report of ILAE Task Force Medical Therapies in Children

    Epilepsia Open . 8(1): 77-89. Number of citations: 14

    [doi:10.1002/epi4.12666]

  • Henshall DC, Arzimanoglou A, Dedeurwaerdere S, Guerrini R, Jozwiak S, Kokaia M, Lerche H, Pitkänen A, Ryvlin P, Simonato M and Sisodiya SM.

    Shaping the future of European epilepsy research: Final meeting report from EPICLUSTER

    EPILEPSY RESEARCH . 189: 107068-107068. Number of citations: 1

    [doi:10.1016/j.eplepsyres.2022.107068]

  • Brunklaus A, Brünger T, Feng T, Fons-Estupina C, Lehikoinen A, Panagiotakaki E, Vintan MA, Symonds J, Andrew J, Arzimanoglou A, Delima S, Gallois J, Hanrahan D, Lesca G, MacLeod S, Marjanovic D, McTague A, Nuñez-Enamorado N, Perez-Palma E, Scott Perry M, Pysden K, Russ-Hall SJ, Scheffer IE, Sully K, Syrbe S, Vaher U, Velayutham M, Vogt J, Weiss S, Wirrell E, Zuberi SM, Lal D, Møller RS, Mantegazza M and Cestèle S.

    The gain of function SCN1A disorder spectrum: novel epilepsy phenotypes and therapeutic implications

    BRAIN . 145(11): 3816-3831. Number of citations: 82

    [doi:10.1093/brain/awac210]

  • Chávez López EK, Aparicio J, Carlos Valera Dávila, Campistol-Plana J, Ramírez-Camacho A, Fons-Estupina C and Arzimanoglou A.

    Pre-surgical evaluation challenges and long-term outcome in children operated on for Low Grade Epilepsy Associated brain Tumors

    EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY . 41: 55-62. Number of citations: 2

    [doi:10.1016/j.ejpn.2022.10.001]

  • Blumcke, I, Biesel, E, Bedenlier, S, Handel, M, Wilmshurst, J, Mehndiratta, MM, Yacubian, EM, Cendes, F, Arzimanoglou A, Beniczky, S, Wolf, P, Giavasi, C, Baxendale, S, Shisler, P and Wiebe, S.

    A structured, blended learning program towards proficiency in epileptology: the launch of the ILAE Academy Level 2 Program

    EPILEPTIC DISORDERS . 24(5): 737-750. Number of citations: 8

    [doi:10.1684/epd.2022.1462]

  • Martinez-Esteve Melnikova A, Pijuan-Marquilles J, Aparicio J, Ramírez-Camacho A, Altisent A, Vilanova-Adell A, Arzimanoglou A, Armstrong-Moron J, Palau F, Hoenicka J and San Antonio-Arce MV.

    The p.Glu787Lys variant in the GRIA3 gene causes developmental and epileptic encephalopathy mimicking structural epilepsy in a female patient

    EUROPEAN JOURNAL OF MEDICAL GENETICS . 65(3): 104442-104442. Number of citations: 3

    [doi:10.1016/j.ejmg.2022.104442]

  • Arzimanoglou A, Pringsheim, M, Kluger, GJ, Genton, P, Perdomo, C and Malhotra, M.

    Safety and efficacy of rufinamide in children and adults with Lennox- Gastaut syndrome: A post hoc analysis from Study 022

    EPILEPSY & BEHAVIOR . 124: . Number of citations: 5

    [doi:10.1016/j.yebeh.2021.108275]

  • Balestrini, S, Arzimanoglou A, Blumcke, I, Scheffer, IE, Wiebe, S, Zelano, J and Walker, MC.

    The aetiologies of epilepsy

    EPILEPTIC DISORDERS . 23(1): 1-16. Number of citations: 72

    [doi:10.1684/epd.2021.1255]

  • Uchitel J, Wallace K, Tran L, Abrahamsen T, Hunanyan A, Prange L, Jasien J, Caligiuri L, Pratt M, Rikard B, Fons-Estupina C, De Grandis E, Vezyroglou A, Heinzen EL, Goldstein DB, Vavassori R, Papadopoulou MT, Cocco I, Moré R, Arzimanoglou A, Panagiotakaki E, Mikati MA, Duke AHC Research Group and French AHC Consortium.

    Alternating hemiplegia of childhood: evolution over time and mouse model corroboration

    brain communications . 3(3): . Number of citations: 11

    [doi:10.1093/braincomms/fcab128]

  • van den Munckhof, B, Arzimanoglou A, Perucca, E, van Teeseling, HC, Leijten, FSS, Braun, KPJ and Jansen, FE.

    Corticosteroids versus clobazam in epileptic encephalopathy with ESES: a European multicentre randomised controlled clinical trial (RESCUE ESES*)

    Trials . 21(1): . Number of citations: 11

    [doi:10.1186/s13063-020-04874-2]